Kidney Disease Clinical Trials

Showing 2501-2520 of 3,346 trials

Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-based Immunosuppressive Protocol

NCT01797315

Transplant recipients have a high risk to develop skin malignancies. This effect depends on the one hand on the immunosuppressive drugs themselves and relates on the other hand on the dosage. Based on the encouraging results of previous, retrospective studies on patients treated with Sirolimus (SRL), these patients should be switched to an immunosuppressive regime including SRL, decreasing the dosage of calcineurin-inhibitors or converting from former immunosuppression. A conversion to a SRL-based therapy is effective in immunosuppression and safe regarding graft and patient survival. This study was designed to assess whether a switch to a SRL-immunosuppressive therapy decreases the incidence/reoccurrence of skin neoplasm.

Renal Transplant Patients at High-risk for Skin Cancer

University Hospital of Berlin40 participantsStarted Mar 2007

COMPLETEDPhase 1

Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Multiple Myeloma and Renal Disease

NCT01949532

The purpose of this study is to see how the body and the cancer react to carfilzomib, including measuring the amount of the study drug in the blood at certain times following dosing. This study is being done in people with normal kidney function and those with end-stage renal disease to see if they respond differently to the study drug.

Relapsed Multiple MyelomaEnd-stage Renal Disease

Amgen26 participantsStarted Jan 2014

Detroit, Michigan, United States • Lake Success, New York, United States • Canton, Ohio, United States +10 more locations

Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-based Immunosuppressive Protocol

Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Multiple Myeloma and Renal Disease

Related Searches

Clinical Trial in Patients With Hypertension and Left Ventricular Dysfunction

The Effects of Pre-transplant Dialysis Modality on Post-transplant Events

Belatacept to Prevent Organ Rejection in Kidney Transplant Patients

Phase III Sequential Open-label Study to Evaluate the Efficacy and Safety of Sorafenib Followed by Pazopanib Versus Pazopanib Followed by Sorafenib in the Treatment of Advanced / Metastatic Renal Cell Carcinoma (SWITCH-II)

Icodextrin Effects on Glucose Transporter Activation and Mediators of Fibrosis

Preventing contrAst Induced Nephropathy After TranscathEter Aortic Valve Replacement

Effectiveness of Point of Care Blood Analysis Obtained From Skin Puncture Blood

Patient Preference Study of Pazopanib Versus Sunitinib in Advanced or Metastatic Kidney Cancer

Effects of Whole-body Vibration Training on the Heart Rate Variability Cardiac in Kidney Transplantation

Fondaparinux as an Anticoagulant in Haemofiltration in Patients With Acute Kidney Failure.

Treatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RAD001 (Everolimus)

Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas With Botulinum Toxin

The Effects of INP on Peripheral Circulation in Dialysis Patients and Patients With PAD and Leg Ulcers

Comparison of Microwave Ablation-Assisted Enucleation and Conventional Laparoscopic Partial Nephrectomy in the Treatment of T1a Renal Cell Carcinoma

Enteric-Coated Mycophenolate Sodium on Quality of Life in Patients With Gastrointestinal Symptoms Related to Mycophenolate Mofetil Therapy After Kidney Transplantation

Comparison Between Partial Nephrectomy and Ablation for Renal Tumor

Contribution of Renal Function to Endothelial Dysfunction in Living Kidney Donors and Transplant Recipients

Effects of Cholecalciferol on Osteoprotegerin Levels in Patients on Peritoneal Dialysis